- Global Pharma News & Resources

ImagineMIC(TM) Releases Advanced Patch Technology for Skilled Nursing Facilities

POUGHKEEPSIE, N.Y., Sept. 23, 2019 /PRNewswire/ -- ImagineMIC™ announces the launch of a groundbreaking new telehealth solution to revolutionize patient care in skilled nursing environments. 

Unlike existing telemedicine platforms which allow for limited clinical evaluations, this new technology provides a telemedicine solution with real-time, actionable hemodynamic information through the combination of a wireless FDA-cleared Biosensor Telemetry Patch, working in tandem with the company's Monitoring Intervention Center (MIC), allowing for enhanced clinical decision-making. The MIC is staffed with a team of ER physicians, NPs, PAs and RNs who review this data 24/7/365, allowing for immediate, on-the-spot clinical decision-making.

The FDA-cleared wireless Biosensor Telemetry Patch can be easily placed on the chest of a resident, which captures, monitors and trends, in real-time, heart rate, respiratory rate, 2-lead ECG, skin temperature and orientation. 

"Most telemetry products on the market are reactive, ours is proactive," explains ImagineMIC™ CEO and founder Dr. Anthony Bacchi. "Most products are simply 'Skyping' whereas our technology utilizes a combination of telemedicine and real-time hemodynamic data allowing for immediate real-time clinical intervention before a medical emergency, such as a rapid change in a resident's condition. Our company's technology used in conjunction with our MIC has proven to significantly reduce hospital readmissions and promote recovery." 

The ImagineMIC™ patch and system is an ideal monitoring choice for health care facilities, providing continuous clinical oversight of patient's health while reducing operational and clinical costs. 

About ImagineMIC

ImagineMIC™ [from the creators of TeliStat™] is a revolutionary medical device company that offers medical care through remote monitoring services with the help of proprietary, HIPPA-compliant medical technology. To learn more, visit


Rachel McIntosh 

View original content:


Editor Details

Last Updated: 23-Sep-2019